Atogepant, a recently approved drug for migraine, may start working as soon as day 1 of treatment, according to a recent study published in Neurology. | Neuroscience ...
Quick Fix? New Migraine Medicine May Start Working Right Away By Dennis Thompson HealthDay Reporter THURSDAY, Dec. 26, 2024 (HealthDay News) -- Migraine patients often suffer a long time before ...
Patients taking Qulipta had a 37% to 61% lower risk for experiencing migraine from the very first day they started taking the drug, according to a new report in the journal Neurology. “With many ...
This new evidence review was funded by AbbVie, the maker of Qulipta. Qulipta and other CGRP-blocking drugs tend to be much more expensive than older migraine drugs, according to the Association of ...
UpToDate: “Acute treatment of migraine in adults.” JAMA: “Acute treatments for episodic migraine in adults: a systematic review and meta-analysis.” JAMA: “Comparison of new ...